Your browser doesn't support javascript.
loading
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Chambers, Tim; Lopez, Jose I; Nicol, David; O'Brien, Tim; Larkin, James; Horswell, Stuart; Stares, Mark; Au, Lewis; Jamal-Hanjani, Mariam; Challacombe, Ben; Chandra, Ashish; Hazell, Steve; Eichler-Jonsson, Claudia; Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lynch, Joanna; Fernando, Archana; Stamp, Gordon; Nye, Emma; Jabbar, Faiz; Spain, Lavinia; Lall, Sharanpreet; Guarch, Rosa; Falzon, Mary; Proctor, Ian; Pickering, Lisa; Gore, Martin; Watkins, Thomas B K; Ward, Sophia; Stewart, Aengus; DiNatale, Renzo; Becerra, Maria F; Reznik, Ed; Hsieh, James J; Richmond, Todd A; Mayhew, George F; Hill, Samantha M; McNally, Catherine D; Jones, Carol; Rosenbaum, Heidi; Stanislaw, Stacey; Burgess, Daniel L; Alexander, Nelson R; Swanton, Charles.
Afiliação
  • Turajlic S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Xu H; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Litchfield K; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Rowan A; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Chambers T; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Lopez JI; Department of Pathology, Cruces University Hospital, Biocruces Institute, University of the Basque Country, Barakaldo, Spain.
  • Nicol D; Department of Urology, the Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
  • O'Brien T; Urology Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Larkin J; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK.
  • Stares M; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Au L; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence London, University College London Cancer Institute, London WC1E 6DD, UK.
  • Challacombe B; Urology Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Chandra A; Department of Cellular Pathology, Guy's & St Thomas' NHS Foundation Trust, London SE1 7EH, UK.
  • Hazell S; Department of Pathology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Eichler-Jonsson C; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Soultati A; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Chowdhury S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Rudman S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Lynch J; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Fernando A; Urology Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Stamp G; Experimental Histopathology Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Nye E; Experimental Histopathology Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Jabbar F; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Spain L; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Lall S; Department of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Guarch R; Department of Pathology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
  • Falzon M; Department of Pathology, University College London Hospitals, London WC1E 6DE, UK.
  • Proctor I; Department of Pathology, University College London Hospitals, London WC1E 6DE, UK.
  • Pickering L; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Gore M; Renal and Skin Units, the Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK.
  • Watkins TBK; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Ward S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence London, University College London Cancer Institute, London WC1E 6DD, UK.
  • Stewart A; Department of Pathology, Cruces University Hospital, Biocruces Institute, University of the Basque Country, Barakaldo, Spain.
  • DiNatale R; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Becerra MF; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reznik E; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hsieh JJ; Molecular Oncology, Department of Medicine, Siteman Cancer Center, Washington University, St. Louis, MO, USA.
  • Richmond TA; Roche Sequencing Solutions, Madison, Research & Development, Madison, WI, 53719, USA.
  • Mayhew GF; Roche Sequencing Solutions, Madison, Research & Development, Madison, WI, 53719, USA.
  • Hill SM; Ventana Medical Systems, Tucson, AZ 85755, USA.
  • McNally CD; Ventana Medical Systems, Tucson, AZ 85755, USA.
  • Jones C; Ventana Medical Systems, Tucson, AZ 85755, USA.
  • Rosenbaum H; Roche Sequencing Solutions, Madison, Research & Development, Madison, WI, 53719, USA.
  • Stanislaw S; Ventana Medical Systems, Tucson, AZ 85755, USA.
  • Burgess DL; Roche Sequencing Solutions, Madison, Research & Development, Madison, WI, 53719, USA.
  • Alexander NR; Ventana Medical Systems, Tucson, AZ 85755, USA.
  • Swanton C; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence London, University College London Cancer Institute, London WC1E 6DD, UK; Department of Medical Oncology, University College London Hospitals, London NW1
Cell ; 173(3): 581-594.e12, 2018 04 19.
Article em En | MEDLINE | ID: mdl-29656895
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Mutação / Metástase Neoplásica Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Mutação / Metástase Neoplásica Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article